celecoxib has been researched along with Endometriosis in 7 studies
Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of celecoxib and rosiglitazone on the implantation and growth of endometriotic-like lesions in a murine model of endometriosis." | 7.77 | The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. ( Barañao, RI; Bilotas, M; Meresman, G; Olivares, C; Ricci, A, 2011) |
| "Celecoxib was the only treatment to significantly reduce the number of lesions established per mouse, their size and vascularized area." | 5.39 | Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? ( Barañao, RI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG, 2013) |
| " Both celecoxib and valdecoxib are indicated for the treatment of primary dysmenorrhea, and may be effective in postoperative pain, including hysterectomy, and pain associated with endometriosis." | 4.81 | COX-2 inhibitors and their role in gynecology. ( Hayes, EC; Rock, JA, 2002) |
| "To evaluate the effects of celecoxib and rosiglitazone on the implantation and growth of endometriotic-like lesions in a murine model of endometriosis." | 3.77 | The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. ( Barañao, RI; Bilotas, M; Meresman, G; Olivares, C; Ricci, A, 2011) |
| " This study aimed to evaluate the expression of NAG-1 in the endometrium and in the absence or presence of endometriosis and to investigate the effect of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, on NAG-1 mRNA levels and apoptosis in human endometrial stromal cells (HESCs)." | 3.76 | Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis. ( Cho, S; Choi, YS; Jeon, YE; Lee, BS; Nam, A; Seo, SK, 2010) |
| "Celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, also has anti-proliferative properties and pro-apoptotic effects on different in vivo and in vitro models, two actions that may be efficacious in therapy for endometriosis." | 3.74 | Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. ( Bilotas, M; Borghi, M; Buquet, R; Meresman, G; Olivares, C; Sueldo, C; Tesone, M, 2008) |
| "Celecoxib was the only treatment to significantly reduce the number of lesions established per mouse, their size and vascularized area." | 1.39 | Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? ( Barañao, RI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olivares, C | 2 |
| Bilotas, M | 2 |
| Buquet, R | 1 |
| Borghi, M | 1 |
| Sueldo, C | 1 |
| Tesone, M | 1 |
| Meresman, G | 2 |
| Seo, SK | 1 |
| Nam, A | 1 |
| Jeon, YE | 1 |
| Cho, S | 1 |
| Choi, YS | 1 |
| Lee, BS | 1 |
| Ricci, A | 1 |
| Barañao, RI | 2 |
| Olivares, CN | 1 |
| Bilotas, MA | 1 |
| Ricci, AG | 1 |
| Meresman, GF | 1 |
| Hayes, EC | 1 |
| Rock, JA | 1 |
| Efstathiou, JA | 1 |
| Sampson, DA | 1 |
| Levine, Z | 1 |
| Rohan, RM | 1 |
| Zurakowski, D | 1 |
| Folkman, J | 1 |
| D'Amato, RJ | 1 |
| Rupnick, MA | 1 |
| Shakiba, K | 1 |
| Falcone, T | 1 |
1 review available for celecoxib and Endometriosis
| Article | Year |
|---|---|
COX-2 inhibitors and their role in gynecology.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Administra | 2002 |
6 other studies available for celecoxib and Endometriosis
| Article | Year |
|---|---|
Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Topics: Apoptosis; Celecoxib; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2008 |
Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis.
Topics: Adult; Apoptosis; Celecoxib; Cyclooxygenase 2 Inhibitors; Endometriosis; Endometrium; Female; Growth | 2010 |
The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.
Topics: Analysis of Variance; Animals; Antigens, CD34; Apoptosis; Celecoxib; Cell Proliferation; Cyclooxygen | 2011 |
Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?
Topics: Anastrozole; Animals; Aromatase Inhibitors; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Combination | 2013 |
Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Disease Mode | 2005 |
Tumour necrosis factor-alpha blockers: potential limitations in the management of advanced endometriosis? A case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 I | 2006 |